Hypergammaglobulinemia (polyclonal gammopathy)’ refers to the overproduction of more than one class of immunoglobulins by plasma cells. It is most commonly associated with liver disease, acute or chronic inflammation, autoimmune disorders, and some malignancies. Hypergammaglobulinemia (polyclonal gammopathy) is generally considered a benign condition that does not progress to overt malignancy, contrary to monoclonal gammopathy of undetermined significance (MGUS). This activity outlines the evaluation and management of ‘hypergammaglobulinemia (polyclonal gammopathy)’ and highlights the role of the inter-professional team in evaluating and treating patients with this condition.
- Provider:StatPearls, LLC
- Activity Link: https://www.statpearls.com/ArticleLibrary/viewarticle/141542
- Start Date: 2023-09-01 05:00:00
- End Date: 2023-09-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - MOC Credit Details: ABS - 1.0 Point; Credit Type(s): Accredited CME (ABS)
ABPATH - 1.0 Point; Credit Type(s): Lifelong Learning (ABPATH)
ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
ABS - 1.0 Point; Credit Type(s): Self-Assessment (ABS) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Gastroenterology, General Surgery, Hematology, Hemostasis & Thrombosis/Coagulation, Hospital Medicine, Internal Medicine, Medical Oncology, Rheumatology
Subscribe
Login
0 Comments
Oldest